{
    "2018-12-20": [
        [
            {
                "time": "2018-12-15",
                "original_text": "李迅雷：买自己买不到的东西",
                "features": {
                    "keywords": [
                        "李迅雷",
                        "投资建议",
                        "消费"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-20",
                "original_text": "港股异动︱同仁堂科技(01666)跌4.78% 北京食药监部门对同仁堂蜂业开展调查",
                "features": {
                    "keywords": [
                        "同仁堂",
                        "蜂蜜门",
                        "北京食药监",
                        "调查"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-21",
                "original_text": "前后云南白药“止血门”后有同仁堂“蜂蜜门”老字号品牌铤而走险缘究竟为何？",
                "features": {
                    "keywords": [
                        "云南白药",
                        "同仁堂",
                        "止血门",
                        "蜂蜜门",
                        "品牌危机"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-22",
                "original_text": "医药股2018：安全黑天鹅接二连三，政策大调整此起彼伏",
                "features": {
                    "keywords": [
                        "医药股",
                        "黑天鹅",
                        "政策调整"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-23",
                "original_text": "医药板块连续下跌医药B触发下折",
                "features": {
                    "keywords": [
                        "医药板块",
                        "连续下跌",
                        "医药B",
                        "下折"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}